ropivacaine has been researched along with Acantholysis Bullosa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellon, N; Bodemer, C; Chaumon, S; Corset, I; Elie, C; Greco, C; Moreno Artero, E; Rabeony, T; Schinkel, N | 1 |
| Casagrande, F; Chambelland, A; Chiaverini, C; Devos, C | 1 |
2 other study(ies) available for ropivacaine and Acantholysis Bullosa
| Article | Year |
|---|---|
Efficacy of topical ropivacaine in children and young adults with hereditary epidermolysis bullosa.
Topics: Child; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica; Humans; Ropivacaine; Young Adult | 2021 |
Topical ropivacaine for analgesia of aplasia cutis congenita in newborns with hereditary epidermolysis bullosa.
Topics: Analgesia; Child; Ectodermal Dysplasia; Epidermolysis Bullosa; Humans; Infant, Newborn; Pain; Prospective Studies; Ropivacaine | 2020 |